Sign up
Quantellect · Congress · Trade Detail
NASDAQ: NTLAIntellia Therapeutics Inc
DemocratHouse

Donald S. Beyer, Jr. sold Intellia Therapeutics Inc (NASDAQ: NTLA)

Donald S. Beyer, Jr. (D-VA), a U.S. Representative, has disclosed 10 trades in Intellia Therapeutics Inc (NTLA) since 2019, 4 purchases and 6 sales, worth an estimated $105K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a sale: Donald S. Beyer, Jr. sold $15,001 - $50,000 of Intellia Therapeutics Inc (NASDAQ: NTLA) on February 28, 2022. Since that trade, NTLA is down -89.07% against the S&P 500 up +77.10%, an outperformance of -166.18%.

Across these filings, Donald S. Beyer, Jr. has been a net seller of NTLA (a buy-to-sell ratio of 0.67). Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

NTLA trades
10
Disclosed Vol
$105K
Buys
4
40%
Sells
6
60%
Buy / Sell
0.67
ratio
First → Last
2019–2022

Donald S. Beyer, Jr.'s NTLA trades vs the price

NTLA is down -89.07% since Donald S. Beyer, Jr. sold on February 28, 2022, versus +77.10% for the S&P 500.

Performance since this trade

Price change since trade
-89.07%
S&P 500 change since trade
+77.10%
Outperformance vs S&P 500
-166.18%

All Donald S. Beyer, Jr. NTLA trades

TradedTypeSizeReturnEst. profit
February 28, 2022SELL$98.85-89.07%
October 29, 2021SELL$132.98-91.88%
September 20, 2021SELL$148.36-92.72%
July 21, 2021SELL$152.75-92.93%
January 15, 2021SELL$81.89-86.81%
November 18, 2020BUY$34.23-68.45%-$5K
August 26, 2020SELL$20.75-47.95%
July 10, 2020BUY$23.81-54.64%-$4K
January 14, 2020BUY$14.52-25.62%-$2K
December 9, 2019BUY$16.72-35.41%-$3K

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

Donald S. Beyer, Jr. & NTLA trading FAQ

Is it legal for Donald S. Beyer, Jr. to trade Intellia Therapeutics Inc (NTLA) stock?

Yes. Members of Congress are allowed to trade individual stocks, including Intellia Therapeutics Inc (NTLA), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did Donald S. Beyer, Jr. sell NTLA?

Donald S. Beyer, Jr. disclosed a sale of $15,001 - $50,000 of Intellia Therapeutics Inc (NTLA) on February 28, 2022, according to public STOCK Act filings.

How has NTLA performed since Donald S. Beyer, Jr.'s trade?

Since Donald S. Beyer, Jr. sold NTLA on February 28, 2022, the stock is down -89.07%, versus +77.10% for the S&P 500 over the same period, an outperformance of -166.18%.

How many times has Donald S. Beyer, Jr. traded NTLA?

Donald S. Beyer, Jr. has disclosed 10 NTLA trades since 2019 (4 purchases and 6 sales). Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional NTLA trades?

Quantellect tracks every disclosed congressional trade in Intellia Therapeutics Inc (NTLA) on the Intellia Therapeutics Inc congressional trading page, which aggregates filings across all members of Congress.

Donald S. Beyer, Jr.'s NTLA tradesAll congressional filings for Intellia Therapeutics IncDonald S. Beyer, Jr.'s full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.